Coronavirus Outbreak: China to lift travel curbs in Hubei province, end lockdown of Wuhan on 8 April as infections begin to abate

Wuhan, the central Chinese city where the virus cases were first detected in December last year on Monday reported one new confirmed case of the COVID-19 after reporting zero cases for five consecutive days

Press Trust of India March 24, 2020 15:37:28 IST
Coronavirus Outbreak: China to lift travel curbs in Hubei province, end lockdown of Wuhan on 8 April as infections begin to abate

Beijing/Wuhan: China on Tuesday said it will lift the travel curbs in Hubei province, where the deadly coronavirus first emerged last year, on Wednesday and will end the three-month lockdown of its capital Wuhan on 8 April, lifting the mass quarantine over the city with a population of over 11 million as the COVID-19 began to abate.

Coronavirus Outbreak China to lift travel curbs in Hubei province end lockdown of Wuhan on 8 April as infections begin to abate

Representational image. AP

Wuhan, the central Chinese city where the virus cases were first detected in December last year on Monday reported one new confirmed case of the COVID-19 after reporting zero cases for five consecutive days.

Hubei province and Wuhan which together have over 56 million population were kept under strict lockdown since 23 January with a ban on all movement of people and transportation.

Residents currently living in other parts of Hubei province will be able to travel with a green health code starting Wednesday, according to a government notice, state-run People's Daily reported.

China to lift travel curbs of coronavirus-hit Hubei province on 25 March and to end lockdown of Wuhan on 8 April, official media reported.

The Hubei Health Commission announced on Tuesday that residents of Wuhan would be allowed to travel outside the city starting 8 April in a bid to resume the outbound movement of people, state-run CGTN TV reported.

Local officials announced plans to gradually ease the severe measures as the virus cases dropped dramatically in recent days.

Hubei, however saw seven new deaths, all of which were in Wuhan, bringing the total number of deaths in the province to 3,160.

The province still has 4,200 patients being treated in hospitals of which 1,203 were still in severe condition and another 336 in critical condition, according to China's National Health Commission.

Hubei has so far reported a total of 67,801 confirmed COVID-19 cases, including 50,006 in Wuhan.

On Tuesday, the NHC reported 78 new confirmed cases, including 74 imported infections, while the death toll from the novel coronavirus increased to 3,277 after seven more fatalities.

Click here to follow LIVE updates on coronavirus outbreak

The overall confirmed cases on the Chinese mainland have reached 81,171 by the end of Monday. This included 3,277 people who died of the disease, 4,735 patients who were still being treated and 73,159 patients discharged after recovery, the NHC said on Tuesday.

Also on Monday, seven deaths and 35 new suspected cases were reported on the mainland with all the deaths in Hubei Province.

According to the Johns Hopkins coronavirus tracker, the death toll from the virus globally has risen to 16,559 with 381,598 cases reported in 168 countries and territories.

Updated Date:

Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.

also read

GAVI vaccine alliance looking at range of prices for COVID-19 shots, sets cap of $40 per dose
World

GAVI vaccine alliance looking at range of prices for COVID-19 shots, sets cap of $40 per dose

Seth Berkley, chief executive of the GAVI vaccine alliance, said they're aiming for tiered pricing for richer and poorer countries to ensure fair global access to COVID-19 shots

Wockhardt strikes deal with UK govt to manufacture, supply COVID-19 vaccines
Business

Wockhardt strikes deal with UK govt to manufacture, supply COVID-19 vaccines

The drug firm is expected to deliver about 60 million doses of multiple vaccines against the coronavirus, including the one co-invented by Oxford and AstraZeneca, in the next few months

Moderna's experimental COVID-19 vaccine induced robust immune response in monkeys, says study
Health

Moderna's experimental COVID-19 vaccine induced robust immune response in monkeys, says study

The candidate vaccine, mRNA-1273, was co-developed by scientists at Moderna and the National Institute of Allergy and Infectious Diseases (NIAID) in the US